At the INVEST DIgital Health conference in Dallas, the Advanced Research Projects Agency for Health (ARPA-H) offered a glimpse of the kind of technology it’s funding. The federal organization funds research across focus areas that are disease agnostic, broad by design, and intersect to foster the creativity and big thinking needed for next-generation innovation.
MedCity News Reporter Marissa Plescia did a series of video interviews with a selection of companies in ARPA-H’s portfolio that exhibited in the Innovation Showcase.
NIRSense
Chief Commercial Officer Dan Rodenhaver discussed how NIRSense‘s biosensor development has created the ability to treat more advanced disease states at home. The challenge is the industry requires new data inputs rather than advanced applications of existing data. In an interview, Rodenhaver told Marissa Plescia that advances in optical sensing technology means that it can collect data one would previously need a blood test to obtain. Funded by the Department of Defense, the business develops prototypes with the goal of finding strategic partners who can commercialize its technology.
Sibel Health
Sibel Health has created a couple of flexible, wireless, wearable vital sign monitors designed to capture vital sign information to identify early signs of patient deterioration. The company’s two wearables include a pulse oximeter and a chest monitor to capture blood oxygen and heart data as well as other patient information. In an interview, Director of Customer Success and Clinical Implementation Beth Schreiber explained how the wearables work and how they can help clinicians.
Picture: Issarawat Tattong, Getty Images